Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01377623 · ClinicalTrials.gov registry record · NA
Pilot Study on the Effect of Dexmedetomidine on Inflammatory Responses in Patients Undergoing Lumbar Spinal Fusion
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT01377623 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 66 participants.
The verdict
NCT01377623, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The aim of the proposed study is to examine the effect of DEX on the inflammatory response in major surgery. More importantly, the investigators will correlate changes in the concentration of inflammatory mediators with meaningful clinical outcomes.
Interventions
- DRUG Placebo group
- DRUG Dexmedetomidine group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2010-09 |
| Est. Completion | 2012-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01377623
The ClinicalTrials.gov registry entry for NCT01377623 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo group is the first listed.
NCT01377623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01377623 about?
NCT01377623 is a clinical study titled "Pilot Study on the Effect of Dexmedetomidine on Inflammatory Responses in Patients Undergoing Lumbar Spinal Fusion". The aim of the proposed study is to examine the effect of DEX on the inflammatory response in major surgery. More importantly, the investigators will correlate changes in the concentration of inflammatory mediators with meaningful clinical outcomes.
What is the current status of trial NCT01377623?
This trial is currently terminated. It is a NA study. The enrollment target is 66 participants. The study started on 2010-09. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01377623?
The interventions under investigation include: Placebo group (DRUG), Dexmedetomidine group (DRUG).
Who is sponsoring clinical trial NCT01377623?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.